tradingkey.logo
tradingkey.logo
Buscar

TELA Bio Inc

TELA
Añadir a la lista de seguimiento
0.706USD
-0.034-4.65%
Cierre 06/26, 16:00ETCotizaciones retrasadas 15 min
31.59MCap. mercado
PérdidaP/E TTM

Más Datos de TELA Bio Inc Compañía

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

Información de TELA Bio Inc

Símbolo de cotizaciónTELA
Nombre de la empresaTELA Bio Inc
Fecha de salida a bolsaNov 08, 2019
Director ejecutivoKoblish (Antony)
Número de empleados209
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 08
Dirección1 Great Valley Parkway, Suite 24
CiudadMALVERN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19355
Teléfono14843202930
Sitio Webhttps://www.telabio.com/
Símbolo de cotizaciónTELA
Fecha de salida a bolsaNov 08, 2019
Director ejecutivoKoblish (Antony)

Ejecutivos de TELA Bio Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+55.91%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de TELA Bio Inc?

Los cinco principales accionistas de TELA Bio Inc son: Mr. Antony Koblish

¿Cuántas instituciones poseen acciones de TELA Bio Inc (TELA)?

A fecha de 2026Q1, 163 instituciones poseen acciones de TELA Bio Inc, con un valor de mercado combinado de aproximadamente 32.85M, lo que representa el 73.39% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -6147477.00.

¿Cuál es la mayor fuente de ganancias de TELA Bio Inc?

El 2026Q1, el segmento empresarial OviTex generó la ganancia más alta para TELA Bio Inc, ascendiendo a 51.22M y representando el 63.81% de la ganancia total.
KeyAI